Bliss GVS Pharma Limited has informed the Exchange regarding Allotment of 52000 Shares.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has allotted 52,000 equity shares of Re. 1 face value to eligible employees who exercised their stock options under the company's ESOP 2019 plan. The exercise price was Rs. 43 per share, with a premium of Rs. 42 per share. As a result, the company's issued and paid-up share capital has risen from 10,54,45,523 to 10,54,97,522 equity shares, aggregating to Rs. 10,54,97,522. The new shares will rank equally with existing shares. The shares carry a mandatory 6-month lock-in period ending December 30, 2025, and are listed on both BSE and NSE.
This is a routine, small ESOP allotment (52,000 shares) with negligible dilution (~0.05%) and is unlikely to materially affect the stock price. The 6-month lock-in means the newly allotted shares cannot be sold until late December 2025.